Cetera Investment Advisers’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.86M Buy
218,111
+207,641
+1,983% +$6.4M 0.01% 1384
2026
Q1
$300K Buy
+10,470
New +$305K ﹤0.01% 3987
2024
Q2
Sell
-160,509
Closed -$3.85M 3830
2024
Q1
$3.85M Buy
+160,509
New +$3.59M 0.01% 1120

Other funds holding REVS

Cetera Investment Advisers's REVS Position: Q2 2026 in Review

Cetera Investment Advisers increased its Columbia Research Enhanced Value ETF (REVS) stake by 1,983% in Q2 2026, buying an estimated $6.4M and bringing the position to 218,111 shares worth $6.86M. The position accounts for 0.01% of the portfolio, ranked #1384.

Cetera Investment Advisers first reported a position in REVS in Q1 2024 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Cetera Investment Advisers held 218,111 shares of Columbia Research Enhanced Value ETF worth $6.86M as of Q2 2026.
  • Cetera Investment Advisers bought 207,641 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $6.4M.
  • Columbia Research Enhanced Value ETF made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1384 holding.
  • Cetera Investment Advisers first reported a position in Columbia Research Enhanced Value ETF in Q1 2024 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.